Analysis of tumor-infiltrating NK and T cells highlights IL-15 stimulation and TIGIT blockade as a combination immunotherapy strategy for soft tissue sarcomas.
Judge SJ, Darrow MA, Thorpe SW, Gingrich AA, O'Donnell EF, Bellini AR, Sturgill IR, Vick LV, Dunai C, Stoffel KM, Lyu Y, Chen S, Cho M, Rebhun RB, Monjazeb AM, Murphy WJ, Canter RJ.
Judge SJ, et al. Among authors: chen s.
J Immunother Cancer. 2020 Nov;8(2):e001355. doi: 10.1136/jitc-2020-001355.
J Immunother Cancer. 2020.
PMID: 33158916
Free PMC article.